The Use of Infliximab in Older Inflammatory Bowel Disease Patients

Authors

Stephanie M. Moleski, Thomas Jefferson University HospitalFollow
Christina C. Lindenmeyer, Thomas Jefferson University HospitalFollow
Patricia L. Kozuch, Thomas Jefferson University HospitalFollow

Document Type

Poster

Publication Date

5-2012

Comments

This poster was presented at the May 2012 Digestive Disease Week in San Diego, California.

Abstract

Limited data suggest anti-tumor necrosis factor (TNF) antibodies have equal efficacy but higher morbidity and mortality in older compared to younger inflammatory bowel disease (IBD) patients(1).

Recommended Citation

Moleski, Stephanie M.; Lindenmeyer, Christina C.; and Kozuch, Patricia L., "The Use of Infliximab in Older Inflammatory Bowel Disease Patients" (2012). Department of Medicine Faculty Papers. Paper 79.
https://jdc.jefferson.edu/medfp/79